Vertebral osteopenia due to bone marrow hyperplasia during interferon-α and ribavirin therapy for chronic hepatitis C

Digestive and Liver Disease

Volumn 35, Issue 10, 2003, Pages 732-734

  Framarin, L ^a   Avataneo, T ^a   Salzedo, E ^a   Badalamenti, S ^a   Tappero, G ^a   Rosina, F ^a  

^a GRADENIGO HOSPITAL   (Italy)

Author keywords

Chronic hepatitis C; Osteopenia; Ribavirin therapy

Indexed keywords

ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; CASE REPORT; CHRONIC HEPATITIS; DENSITOMETRY; DISEASE SEVERITY; DRUG INDUCED DISEASE; DRUG RESPONSE; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPERPLASIA; LIVER BIOPSY; LUMBAR SPINE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; OSTEOPENIA; SERODIAGNOSIS; SPINE RADIOGRAPHY;

EID: 3142741339     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00418-3     Document Type: Article

References (11)

1. Lauer GM, Walker BD. Hepatitis C virus infection. New Engl J Med 2001;345:41-52.
2. Reichard O, Schwarcz R, Weiland O. Therapy of hepatitis C. Alpha interferon and ribavirin. Hepatology 1997;26(Suppl 1):108S-10S.
3. Mc Hutchinson JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rutsgi VK, et al. Interferon alpha 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. New Engl J Med 1998;339:1485-92.
4. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G, et al. Randomised trial of interferon α2b plus ribavirin for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998;352:1426-52.
5. Goldstein SR, Martino FP, Cort S. Ribavirin capsules (SCH 18908) investigator's brochure. Schering-Plough Research Institute; 1997.
6. Jaap S, Martin P. Hemolytic anemia and the treatment of chronic hepatitis C. J Clin Gastroenterol 1999;28:289-90.
7. Tappero G, Ballare' M, Farina M, Negro F. Severe anemia following combined alpha-interferon/ribavirin therapy of chronic hepatitis C. J Hepatol 1998;29:1033-4.
8. The Members of the BASL Steering Committee, Van Vlierberghe H, Delanghe JR, De Vos M, Leroux-Roel G. Factors influencing ribavirin-induced hemolysis. J Hepatol 2001;34:911-6.
9. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-9.
10. Solis-Herruzo JA, Castellano G, Fernandez I, Munoz R, Hawkins F. Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C. J Hepatol 2000;33:812-7.
11. Trombetti A, Giostra E, Mentha G, Negro F, Rizzoli R. Lack of evidence for ribavirin-induced bone loss. Hepatology 2002;36:255-7.